Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172287 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

623

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium (Ba679 BR)
DRUG: Salmeterol
DRUG: Placebo (for Tiotropium )
DRUG: Placebo (for Salmeterol)

Sponsor

Boehringer Ingelheim